2 results
Approved WMORecruiting
To attenuate the impact and duration of delayed graft funtion by dampening schemia reperfusion injury
Approved WMORecruiting
We hypothesize that Kenalog-40, Kenalog-10 and Depo-Medrol 40 mg/ml have a different effectiveness in treating trigger fingers in both primary as secondary outcomes.